Bacordo, Helenda T.

HRN: 10-84-13  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/25/2026
CEFTRIAXONE 1G (VIAL)
01/25/2026
02/01/2026
IV
2g
OD
UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: